Literature DB >> 9811748

A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer.

M J O'Connor1, W Stünkel, H Zimmermann, C H Koh, H U Bernard.   

Abstract

Regulation of the human papillomavirus type 16 (HPV-16) E6 promoter is a complex process in which transcriptional repression as well as activation plays an important role. Here, we identify a negative regulatory element that in the context of a continuous long control region fragment overcomes the activation of the HPV-16 enhancer. This silencing element, which we have termed a PSM (papillomavirus silencing motif), consists of two copies of the sequence 5'-TAYAATAAT-3' that overlap the origin of replication. Each copy of this 9-bp sequence binds the same unknown cellular factor, which we refer to as PSM-BP (PSM binding protein). Both copies of the binding sequence are required for transcriptional repression, and we provide evidence that suggests that this particular organization results in the stabilization of a PSM-BP dimer. The silencing motif, while functioning in either orientation, showed a positional requirement between the enhancer and the promoter. Experiments with both a heterologous enhancer and a promoter also demonstrated a general ability of this element to function as a transcriptional silencer in non-HPV systems. Our findings provide an important addition to our understanding of HPV-16 gene regulation and an interesting model for the study of transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811748      PMCID: PMC110540     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

Review 2.  The papillomavirus E2 regulatory proteins.

Authors:  A A McBride; H Romanczuk; P M Howley
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

Review 3.  Papillomavirus DNA replication.

Authors:  L T Chow; T R Broker
Journal:  Intervirology       Date:  1994       Impact factor: 1.763

4.  Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element.

Authors:  M O'Connor; H U Bernard
Journal:  Virology       Date:  1995-02-20       Impact factor: 3.616

5.  Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16.

Authors:  D Apt; T Chong; Y Liu; H U Bernard
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

6.  Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF.

Authors:  S C Dollard; J L Wilson; L M Demeter; W Bonnez; R C Reichman; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

Review 7.  Human papillomaviruses.

Authors:  H zur Hausen; E M de Villiers
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

8.  YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity.

Authors:  M J O'Connor; S H Tan; C H Tan; H U Bernard
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.

Authors:  S H Tan; B Gloss; H U Bernard
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

10.  Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.

Authors:  T Ishiji; M J Lace; S Parkkinen; R D Anderson; T H Haugen; T P Cripe; J H Xiao; I Davidson; P Chambon; L P Turek
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  8 in total

1.  A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.

Authors:  C A Lundquist; J L Meier; M F Stinski
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.

Authors:  M J O'Connor; W Stünkel; C H Koh; H Zimmermann; H U Bernard
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.

Authors:  K J Watts; C H Thompson; Y E Cossart; B R Rose
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.

Authors:  W Stünkel; Z Huang; S H Tan; M J O'Connor; H U Bernard
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.

Authors:  K W Vance; M S Campo; I M Morgan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Cellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter.

Authors:  Philip E Lashmit; Christopher A Lundquist; Jeffery L Meier; Mark F Stinski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  A non-radioactive PCR-SSCP analysis allows to distinguish between HPV 16 European and Asian-American variants in squamous cell carcinomas of the uterine cervix in Colombia.

Authors:  Pablo Moreno-Acosta; Mónica Molano; Antonio Huertas; Myriam Sánchez de Gómez; Alfredo Romero; Mauricio González; María Mercedes Bravo; Alejandro García-Carrancá
Journal:  Virus Genes       Date:  2008-05-30       Impact factor: 2.332

8.  Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies.

Authors:  T Kozuka; Y Aoki; K Nakagawa; K Ohtomo; H Yoshikawa; K Matsumoto; K Yoshiike; T Kanda
Journal:  Jpn J Cancer Res       Date:  2000-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.